At-Home Genetic Testing Market Expected To Grow At 15.5% CAGR Through 2030: What Businesses Need To Know
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
At-Home Genetic Testing Market Forecast: Value Set To Climb From $4.66 Billion To $8.29 Billion
The size of the at-home genetic testing market has experienced rapid expansion in recent years. Projections indicate it will increase from $4.02 billion in 2025 to $4.66 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.8%. This historical growth can be attributed to various factors, including heightened consumer interest in personalized health insights, reduced costs of genetic sequencing, the proliferation of online health platforms, an increased understanding of hereditary disease risks, and the widespread availability of convenient home sampling kits.
The at-home genetic testing market is anticipated to experience substantial growth in the upcoming years. Its valuation is projected to reach $8.29 billion by 2030, displaying a compound annual growth rate (CAGR) of 15.5%. This expansion during the forecast period can be attributed to the increasing integration of genetic data with digital health platforms, a rising demand for preventive healthcare solutions, the broadening of personalized nutrition and fitness planning, clearer regulatory frameworks for DTC testing, and advancements in genomic data analytics. Key trends identified for the forecast period encompass the increasing adoption of direct-to-consumer genetic health kits, a growing demand for ancestry and ethnicity analysis, wider utilization of pharmacogenomic testing, the expansion of personalized wellness insights, and an intensified focus on data privacy and consent.
Get A Free Sample Report With In-Depth Market Insights:
At-Home Genetic Testing Market Expansion Drivers: What’s Shaping Future Growth?
The rising embrace of telehealth is projected to fuel the expansion of the at-home genetic testing market moving forward. Telehealth involves employing digital communication and information technologies, such as computers, smartphones, and video conferencing, to remotely deliver and oversee healthcare services. Its increasing uptake stems from its convenience and ability to enhance healthcare accessibility, particularly for individuals in remote, rural, or underserved regions. At-home genetic testing complements telehealth by supplying customized genetic insights that medical professionals can utilize during virtual appointments. This information enables doctors to customize treatment strategies, oversee long-term conditions, and provide accurate health advice remotely. For example, in November 2025, the Australian Bureau of Statistics (ABS), an Australia-based government statistical agency, reported that 22.5% of Australians utilized telehealth services during 2024–25. Of those who had a telehealth consultation, 90.3% indicated they would use telehealth again if available, an increase from 89.2% in 2023–24, signifying growing acceptance and ongoing adoption. Consequently, the increasing use of telehealth stimulates the growth of the at-home genetic testing market.
At-Home Genetic Testing Market Segments: Where Is Growth Concentrated?
The at-home genetic testing market covered in this report is segmented –
1) By Test Type: Ancestry Testing, Health And Wellness Testing, Disease Risk Assessment, Carrier Testing, Other Test Types
2) By Sample Type: Saliva, Blood, Cheek Swab, Urine, Other Specimens
3) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray, Other Technologies
4) By Application: Personal Use, Clinical Use, Research Use, Pharmaceutical Use, Nutritional Use
5) By Distribution Channel: Online Platforms, Retail Pharmacies, Other Distribution Channels
Subsegments:
1) By Ancestry Testing: Ethnicity Estimation, Genetic Heritage Mapping, Migration Pattern Analysis, Deep Ancestry Tracing
2) By Health And Wellness Testing: Nutrigenomics, Fitness and Exercise Response, Sleep Pattern Analysis, Stress and Behavioral Traits, Skin and Aging Traits
3) By Disease Risk Assessment: Cardiovascular Disease Risk, Cancer Risk Assessment, Neurological Disorder Risk, Autoimmune Disease Risk, Metabolic Disorder Risk
4) By Carrier Testing: Cystic Fibrosis Carrier Screening, Tay-Sachs Disease Screening, Sickle Cell Anemia Carrier Testing, Thalassemia Carrier Testing, Fragile X Syndrome Screening
5) By Other Test Types: Pharmacogenomics (Drug Response), Prenatal Genetic Testing, Pediatric Genetic Testing, Rare Disease Screening, Behavioral Trait Testing
At-Home Genetic Testing Market Strategic Trends: What Defines The Next Growth Phase?
Leading firms within the at-home genetic testing market are increasingly prioritizing the incorporation of innovative offerings like health membership models, aiming to deliver ongoing, tailored preventive care. These health membership models are subscription programs designed to offer continuous access to services including advanced genetic testing, routine biomarker tracking, and virtual consultations with clinicians, thereby enabling users to monitor health risks constantly and obtain customized prevention strategies. As an example, in November 2023, 23andMe, a personal genomics company based in the US, introduced 23andMe+ Total Health. This membership program provides clinical-grade exome sequencing of over 100 medically pertinent genes associated with more than 55 health conditions, along with biannual testing for 55+ blood biomarkers, and virtual consultations from genetics-trained clinicians. The service aims to facilitate personalized prevention planning by combining sophisticated genetic insights with continuous monitoring and telehealth assistance, thereby transforming at-home genetic testing from a singular product into a sustained preventive health offering.
At-Home Genetic Testing Market Key Participants And Competitive Landscape
Major companies operating in the at-home genetic testing market are AncestryDNA, LetsGetChecked, Helix OpCo LLC, Everlywell Inc., Genos Inc., Vitagene Inc., Orig3n Inc., Mapmygenome India Limited, CircleDNA, EasyDNA Limited, African Ancestry Inc., Futura Genetics Ltd., Living DNA Ltd., Nebula Genomics Inc., TellmeGen S.L., Xcode Life Sciences Pvt Ltd., Color Health Inc., MyHeritage Ltd, FamilyTreeDNA (Gene By Gene Ltd), Color Genomics Inc, DNAfit, Pathway Genomics Inc.
View The Full At-Home Genetic Testing Market Report:
At-Home Genetic Testing Market Regional Analysis And Top Geography
North America was the largest region in the at-home genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the at-home genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
